PDCD1 and neoplasm: In B-lymphoma cells, miR-155 increased the expression of PD-L1 through directly combining with the 3′-UTR, aggravating CD8+ T-cell necrobiosis, and preserving neoplasm immunity in a particularly PD-1/PD-L1-dependent manner (19).